S&P 500 ETF jumps 2% after hours on report Gilead drug showing effectiveness treating coronavirusCNBC • 04/16/20
Gilead stock surges after report says coronavirus drug trial shows encouraging early resultsCNBC • 04/16/20
Early peek at data on Gilead coronavirus drug suggests patients are responding to treatmentCNBC • 04/16/20
Gilead Sciences’ Remdesivir Data Release Brings Much Needed Relief for Patients and InvestorsThe Motley Fool • 04/16/20
Covid Report: Gilead Trips After Coronavirus Drug Test Scrapped In ChinaInvestors Business Daily • 04/15/20
RBC Has 5 Biotech Stocks Rated Outperform With Up to 100% Upside Potential24/7 Wall Street • 04/14/20
Early Look at Gilead Sciences' Experimental Coronavirus Treatment DisappointsThe Motley Fool • 04/11/20